SPY330.06+1.27 0.39%
DIA268.41+1.69 0.63%
IXIC10,941.17+38.37 0.35%

B. Riley FBR Reinstates Buy on Acasti Pharma, Announces $8 Price Target

B. Riley FBR reinstates Acasti Pharma (NASDAQ:ACST) with a Buy and announces $8 price target.

Benzinga · -

B. Riley FBR reinstates Acasti Pharma (NASDAQ:ACST) with a Buy and announces $8 price target.